{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:50:45Z","timestamp":1790121045452,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11606-025-09472-z","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T14:58:28Z","timestamp":1753455508000},"page":"3477-3487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Physician Perceptions, Knowledge, and Implementation of Lipid-Lowering Guidelines in the USA"],"prefix":"10.1007","volume":"41","author":[{"given":"Taruja","family":"Karmarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori D.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Exter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4662-8800","authenticated-orcid":false,"given":"Jordana K.","family":"Schmier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayeli P.","family":"Jayade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoscar M.","family":"Ogando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"9472_CR1","unstructured":"Centers for Disease Control and Prevention. Underlying Cause of Death, 1999\u20132018. CDC WONDER Online Database. . Atlanta, GA. Accessed March 12, 2020."},{"key":"9472_CR2","doi-asserted-by":"publisher","unstructured":"Cholesterol Treatment Trialists C, Mihaylova B, Emberson J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(12)60367-5.","DOI":"10.1016\/S0140-6736(12)60367-5"},{"issue":"8","key":"9472_CR3","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145(8):e153-e639. https:\/\/doi.org\/10.1161\/CIR.0000000000001052.","journal-title":"Circulation."},{"issue":"2","key":"9472_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/011573403x283174240110025442","volume":"20","author":"H Salim","year":"2024","unstructured":"Salim H, Musmar B, Saifi M, et al. The Impact of Polypill on Adherence and Cardiovascular Outcomes: A Comprehensive Systematic Review with Meta-Analysis. Curr Cardiol Rev. 2024;20(2):61-71. https:\/\/doi.org\/10.2174\/011573403x283174240110025442.","journal-title":"Curr Cardiol Rev."},{"issue":"25","key":"9472_CR5","doi-asserted-by":"publisher","first-page":"e1046","DOI":"10.1161\/CIR.0000000000000624","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1046-e1081. https:\/\/doi.org\/10.1161\/CIR.0000000000000624.","journal-title":"Circulation."},{"issue":"12","key":"9472_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/jamacardio.2023.3931","volume":"8","author":"A Sayed","year":"2023","unstructured":"Sayed A, Navar AM, Slipczuk L, et al. Prevalence, awareness, and treatment of elevated LDL cholesterol in US adults, 1999-2020. JAMA Cardiol. 2023;8(12):1185-1187. https:\/\/doi.org\/10.1001\/jamacardio.2023.3931.","journal-title":"JAMA Cardiol."},{"key":"9472_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2020.100010","volume":"1","author":"AC Klimchak","year":"2020","unstructured":"Klimchak AC, Patel MY, Iorga SR, Kulkarni N, Wong ND. Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States. Am J Prev Cardiol. 2020;1:100010. https:\/\/doi.org\/10.1016\/j.ajpc.2020.100010.","journal-title":"Am J Prev Cardiol."},{"issue":"24","key":"9472_CR8","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.003.","journal-title":"J Am Coll Cardiol."},{"key":"9472_CR9","unstructured":"Grundy SM, Feingold KR. Guidelines for the Management of High Blood Cholesterol. In: Feingold KR, Anawalt B, Blackman MR, et al, eds. Endotext. 2000."},{"issue":"6","key":"9472_CR10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jacl.2020.09.001","volume":"14","author":"JA Tunoa","year":"2020","unstructured":"Tunoa JA, Billups SJ, Lowe RN, Saseen JJ. Early impact of the 2018 AHA\/ACC\/multisociety cholesterol guideline on lipid monitoring after statin initiation. J Clin Lipidol. 2020;14(6):784-790. https:\/\/doi.org\/10.1016\/j.jacl.2020.09.001.","journal-title":"J Clin Lipidol."},{"key":"9472_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ahj.2018.09.003","volume":"206","author":"LL Zullig","year":"2018","unstructured":"Zullig LL, Egbuonu-Davis L, Trasy A, Oshotse C, Goldstein KM, Bosworth HB. Countering clinical inertia in lipid management: Expert workshop summary. Am Heart J. 2018;206:24-29. https:\/\/doi.org\/10.1016\/j.ahj.2018.09.003.","journal-title":"Am Heart J."},{"key":"9472_CR12","doi-asserted-by":"publisher","unstructured":"McCormick D, Bhatt DL, Bays HE, et al. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model. J Manag Care Spec Pharm. 2020;26(12):1517\u20131528. https:\/\/doi.org\/10.18553\/jmcp.2020.26.12.1517.","DOI":"10.18553\/jmcp.2020.26.12.1517"},{"issue":"8","key":"9472_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005404","volume":"12","author":"KD Myers","year":"2019","unstructured":"Myers KD, Farboodi N, Mwamburi M, et al. Effect of access to prescribed PCSK9 inhibitors on cardiovascular outcomes. Circ Cardiovasc Qual Outcomes. 2019;12(8):e005404. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.118.005404.","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"1","key":"9472_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/clc.23935","volume":"46","author":"NR Desai","year":"2023","unstructured":"Desai NR, Farbaniec M, Karalis DG. Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clin Cardiol. 2023;46(1):13-21. https:\/\/doi.org\/10.1002\/clc.23935.","journal-title":"Clin Cardiol."},{"key":"9472_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2147\/ppa.S29092","volume":"6","author":"M Casula","year":"2012","unstructured":"Casula M, Tragni E, Catapano AL. Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence. 2012;6:805-14. https:\/\/doi.org\/10.2147\/ppa.S29092.","journal-title":"Patient Prefer Adherence."},{"issue":"10","key":"9472_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamacardio.2019.3247","volume":"4","author":"LS Mehta","year":"2019","unstructured":"Mehta LS, Fisher K, Rzeszut AK, et al. Current demographic status of cardiologists in the United States. JAMA Cardiol. 2019;4(10):1029-1033. https:\/\/doi.org\/10.1001\/jamacardio.2019.3247.","journal-title":"JAMA Cardiol."},{"issue":"2","key":"9472_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jacc.2015.05.030","volume":"66","author":"BJ Hirsh","year":"2015","unstructured":"Hirsh BJ, Smilowitz NR, Rosenson RS, Fuster V, Sperling LS. Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement. J Am Coll Cardiol. 2015;66(2):184-92. https:\/\/doi.org\/10.1016\/j.jacc.2015.05.030.","journal-title":"J Am Coll Cardiol."},{"issue":"6","key":"9472_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jacc.2013.09.053","volume":"63","author":"TM Maddox","year":"2014","unstructured":"Maddox TM, Chan PS, Spertus JA, et al. Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014;63(6):539-46. https:\/\/doi.org\/10.1016\/j.jacc.2013.09.053.","journal-title":"J Am Coll Cardiol."},{"issue":"20","key":"9472_CR19","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.jacc.2024.03.402","volume":"83","author":"MD Shapiro","year":"2024","unstructured":"Shapiro MD, German CA. Early inclisiran use in atherosclerotic cardiovascular disease: overcoming therapeutic inertia. J Am Coll Cardiol. 2024;83(20):1953-1956. https:\/\/doi.org\/10.1016\/j.jacc.2024.03.402.","journal-title":"J Am Coll Cardiol."},{"key":"9472_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-4505-13-1","volume":"13","author":"SR Hanney","year":"2015","unstructured":"Hanney SR, Castle-Clarke S, Grant J, et al. How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice. Health Res Policy Syst. 2015;13:1. https:\/\/doi.org\/10.1186\/1478-4505-13-1.","journal-title":"Health Res Policy Syst."},{"issue":"12","key":"9472_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","volume":"104","author":"ZS Morris","year":"2011","unstructured":"Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510-20. https:\/\/doi.org\/10.1258\/jrsm.2011.110180.","journal-title":"J R Soc Med."},{"issue":"1","key":"9472_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13012-017-0555-2","volume":"12","author":"DM Gupta","year":"2017","unstructured":"Gupta DM, Boland RJ, Jr., Aron DC. The physician's experience of changing clinical practice: a struggle to unlearn. Implement Sci. 2017;12(1):28. https:\/\/doi.org\/10.1186\/s13012-017-0555-2.","journal-title":"Implement Sci."},{"issue":"14","key":"9472_CR23","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jacc.2017.07.745","volume":"70","author":"DM Lloyd-Jones","year":"2017","unstructured":"Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017;70(14):1785-1822. https:\/\/doi.org\/10.1016\/j.jacc.2017.07.745.","journal-title":"J Am Coll Cardiol."},{"issue":"Suppl 1","key":"9472_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc23-Sint","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. Introduction and Methodology: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S1-S4. https:\/\/doi.org\/10.2337\/dc23-Sint.","journal-title":"Diabetes Care."},{"issue":"1","key":"9472_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1001\/jamacardio.2022.4018","volume":"8","author":"AJ Blood","year":"2023","unstructured":"Blood AJ, Cannon CP, Gordon WJ, et al. Results of a remotely delivered hypertension and lipid program in more than 10\u202f000 patients across a diverse health care network. JAMA Cardiol. 2023;8(1):12-21. https:\/\/doi.org\/10.1001\/jamacardio.2022.4018.","journal-title":"JAMA Cardiol."},{"key":"9472_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131400","volume":"395","author":"H Zheng","year":"2024","unstructured":"Zheng H, Yin Z, Luo X, Zhou Y, Zhang F, Guo Z. Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999-2018. Int J Cardiol. 2024;395:131400. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131400.","journal-title":"Int J Cardiol."},{"issue":"15","key":"9472_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2023.2854","volume":"329","author":"NJ Pagidipati","year":"2023","unstructured":"Pagidipati NJ, Nelson AJ, Kaltenbach LA, et al. Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial. JAMA. 2023;329(15):1261-1270. https:\/\/doi.org\/10.1001\/jama.2023.2854.","journal-title":"JAMA."},{"issue":"9","key":"9472_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cjca.2016.04.003","volume":"32","author":"DH Kim","year":"2016","unstructured":"Kim DH, Rich MW. Patient-centred care of older adults with cardiovascular disease and multiple chronic conditions. Can J Cardiol. 2016;32(9):1097-107. https:\/\/doi.org\/10.1016\/j.cjca.2016.04.003.","journal-title":"Can J Cardiol."},{"key":"9472_CR29","unstructured":"Centers for Medicare and Medicaid Services. MIPS Measure #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease. 2024."},{"key":"9472_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/VHRM.S82710","volume":"11","author":"S Setia","year":"2015","unstructured":"Setia S, Fung SS, Waters DD. Doctors' knowledge, attitudes, and compliance with 2013 ACC\/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vasc Health Risk Manag. 2015;11:303-10. https:\/\/doi.org\/10.2147\/VHRM.S82710.","journal-title":"Vasc Health Risk Manag."},{"issue":"1","key":"9472_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12944-020-01265-z","volume":"19","author":"PJ Barter","year":"2020","unstructured":"Barter PJ, Yamashita S, Laufs U, et al. Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey. Lipids Health Dis. 2020;19(1):131. https:\/\/doi.org\/10.1186\/s12944-020-01265-z.","journal-title":"Lipids Health Dis."},{"issue":"1","key":"9472_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12325-022-02344-6","volume":"40","author":"N Qureshi","year":"2023","unstructured":"Qureshi N, Antoniou S, Cornel JH, et al. European physician survey characterizing the clinical pathway and treatment patterns of patients post-myocardial infarction. Adv Ther. 2023;40(1):233-251. https:\/\/doi.org\/10.1007\/s12325-022-02344-6.","journal-title":"Adv Ther."},{"issue":"3","key":"9472_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jacc.2014.12.001","volume":"65","author":"Z Fanari","year":"2015","unstructured":"Fanari Z, Weiss SA. Academic versus private cardiology: preparing for a successful career after fellowship. J Am Coll Cardiol. 2015;65(3):303-4. https:\/\/doi.org\/10.1016\/j.jacc.2014.12.001.","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"9472_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12909-020-02085-6","volume":"20","author":"MM Braxton","year":"2020","unstructured":"Braxton MM, Infante Linares JL, Tumin D, Campbell KM. Scholarly productivity of faculty in primary care roles related to tenure versus non-tenure tracks. BMC Med Educ. 2020;20(1):174. https:\/\/doi.org\/10.1186\/s12909-020-02085-6.","journal-title":"BMC Med Educ."},{"issue":"15","key":"9472_CR35","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1001\/jama.2021.15319","volume":"326","author":"R Brignardello-Petersen","year":"2021","unstructured":"Brignardello-Petersen R, Carrasco-Labra A, Guyatt GH. How to interpret and use a clinical practice guideline or recommendation: users' guides to the medical literature. JAMA. 2021;326(15):1516-1523. https:\/\/doi.org\/10.1001\/jama.2021.15319.","journal-title":"JAMA."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09472-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09472-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09472-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:01:54Z","timestamp":1789174914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09472-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9472"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09472-z","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As described in \u201cMethods,\u201d the study was reviewed by an institutional review board (IRB) and was deemed exempt from IRB oversight. Potential participants were asked to indicate that they were willing to participate in this survey research prior to entry into the survey questions.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors JKS, OMY, and SPJ are\/were employees of OPEN Health, which received funding from Merck to conduct this survey project. Authors TK, LDB, and JE are\/were employees of Merck & Co, LLC. Author SB has provided consulting or advisory board support for Altimmune, Amgen, Beren Therapeutics, Boehringer Ingelheim, Eli Lilly, Esperion, Ionis Pharmaceuticals, Madrigal Pharmaceuticals, Merck, Novartis, and Regeneron. Author RS has been a paid consultant to Merck, Pfizer, Amgen, and Regeneron.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}